Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxorubicin (Primary) ; Ethiodized oil; Polyvinyl alcohol
- Indications Liver cancer
- Focus Registrational; Therapeutic Use
- Acronyms HiQuality
Most Recent Events
- 07 May 2021 Biomarkers information updated
- 31 Oct 2013 Planned end date changed from 1 Dec 2020 to 1 Dec 2022 as reported by ClinicalTrials.gov.
- 06 Jun 2013 Planned end date changed from 1 Sep 2014 to 1 Dec 2020 as reported by ClinicalTrials.gov.